BioAtla, Inc. (BCAB) NASDAQ
3.65
+0.12(+3.40%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.65
+0.12(+3.40%)
Currency In USD
| Market Cap | 33.4M |
| Enterprise Value | 32.48M |
| P/E Ratio | -0.11 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 2.3 |
| Price/Book Ratio | -0.15 |
| Enterprise/Revenue | 4.37 |
| Enterprise/EBITDA | -0.18 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -25.31 |
| Operating Margin | -25.25 |
| Return On Assets | -5.91 |
| Return On Equity | 1.67 |
| Revenue | 2M |
| Revenue/Share | 1.33 |
| Gross Profit | 2M |
| EBITDA | -58.93M |
| Net Income | -59.61M |
| Diluted EPS | -50.5 |
| Total Cash | 1.96M |
| Total Cash/Share | 1.31 |
| Total Debt | 6.09M |
| Total Debt/Equity | -0.16 |
| Current Ratio | 0.15 |
| Book Value Per Share | -24.85 |
| 52-Week Change | -85.69 |
| 52-Week High | 71.5 |
| 52-Week Low | 3.26 |
| Moving Average 50 Days | 5.1 |
| Moving Average 200 Days | 21.59 |
| Average Volume | 38,484 |
| Shares Outstanding | 1.26M |
| % Held by Institutions | 26.14 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
| Last Split Date | April 06, 2026 |